Related references
Note: Only part of the references are listed.MiR-130b increases fibrosis of HMC cells by regulating the TGF-β1 pathway in diabetic nephropathy
Yujin Ma et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
Antidiabetic and Antiobesity Effects of Artemether in db/db Mice
Yu Guo et al.
BIOMED RESEARCH INTERNATIONAL (2018)
Chinese Medicine in the Battle Against Obesity and Metabolic Diseases
Lingyan Xu et al.
FRONTIERS IN PHYSIOLOGY (2018)
Protein kinases: mechanisms and downstream targets in inflammation-mediated obesity and insulin resistance
Kalyana C. Nandipati et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2017)
Effect of transportation and pre-slaughter water shower spray with resting on AMP-activated protein kinase, glycolysis and meat quality of broilers during summer
Tong Xing et al.
ANIMAL SCIENCE JOURNAL (2016)
Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy
Guanghong Jia et al.
NATURE REVIEWS ENDOCRINOLOGY (2016)
Artemisinin derivatives prevent obesity by inducing browning of WAT and enhancing BAT function
Ping Lu et al.
CELL RESEARCH (2016)
Artemisia annua Leaf Extract Attenuates Hepatic Steatosis and Inflammation in High-Fat Diet-Fed Mice
Kyung Eun Kim et al.
JOURNAL OF MEDICINAL FOOD (2016)
β Cell Dysfunction Versus Insulin Resistance in the Pathogenesis of Type 2 Diabetes in East Asians
Daisuke Yabe et al.
CURRENT DIABETES REPORTS (2015)
FoxO1 integrates direct and indirect effects of insulin on hepatic glucose production and glucose utilization (vol 6, 7079, 2015)
Insug O-Sullivan et al.
NATURE COMMUNICATIONS (2015)
Differential anti-diabetic effects and mechanism of action of charantin-rich extract of Taiwanese Momordica charantia between type 1 and type 2 diabetic mice
Hsien-Yi Wang et al.
FOOD AND CHEMICAL TOXICOLOGY (2014)
Lipid-lowering effects of Danhong injection on hyperlipidemia rats
Juan Chen et al.
JOURNAL OF ETHNOPHARMACOLOGY (2014)
Cellular Fatty Acid Metabolism and Cancer
Erin Currie et al.
CELL METABOLISM (2013)
Treatment of Diabetes Using Traditional Chinese Medicine: Past, Present and Future
Xiao-Lin Tong et al.
AMERICAN JOURNAL OF CHINESE MEDICINE (2012)
Hepatic mTORC2 Activates Glycolysis and Lipogenesis through Akt, Glucokinase, and SREBP1c
Asami Hagiwara et al.
CELL METABOLISM (2012)
Acetyl-CoA Carboxylase 2-/- Mutant Mice are Protected against Fatty Liver under High-fat, High-carbohydrate Dietary and de Novo Lipogenic Conditions
Lutfi Abu-Elheiga et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Modernization of traditional Chinese medicine
De-an Guo et al.
JOURNAL OF ETHNOPHARMACOLOGY (2012)
The worldwide epidemiology of type 2 diabetes mellitus-present and future perspectives
Lei Chen et al.
NATURE REVIEWS ENDOCRINOLOGY (2012)
AMPK: a nutrient and energy sensor that maintains energy homeostasis
D. Grahame Hardie et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
Egr-1 decreases adipocyte insulin sensitivity by tilting PI3K/Akt and MAPK signal balance in mice
Xiao Yu et al.
EMBO JOURNAL (2011)
Traditional Chinese Medicines in Treatment of Patients with Type 2 Diabetes Mellitus
Weidong Xie et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2011)
The AMPK signalling pathway coordinates cell growth, autophagy and metabolism
Maria M. Mihaylova et al.
NATURE CELL BIOLOGY (2011)
Artemisinin activity against Plasmodium falciparum requires hemoglobin uptake and digestion
Nectarios Klonis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state
Marc Foretz et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Fatty acid metabolism: target for metabolic syndrome
Salih J. Wakil et al.
JOURNAL OF LIPID RESEARCH (2009)
Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus (Withdrawn paper, art. no. CD002967, 2006)
S Salpeter et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2006)
Strength training increases insulin-mediated glucose uptake, GLUT4 content, and insulin signaling in skeletal muscle in patients with type 2 diabetes
MK Holten et al.
DIABETES (2004)
Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes
SE Nikoulina et al.
DIABETES (2000)
Share Paper
